Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 ...

French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which would be done between now and the end of December.

Sanofi declined to comment to Pharmaceutical Technology when asked for further details on the latest share buyback. Shares in the Paris-listed company opened with a deficit of 2.8% on 7 February ...

Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the effort.

Management is trying to decide further details such as whether to list the separated business on the Euronext Paris stock exchange. Sanofi’s leaders have also not yet decided what will go into ...

Sanofi shares rose as much as 1.9% in Paris trading and have gained about 10% this year, outperforming a 4.5% increase in a Bloomberg index of European pharmaceutical companies. Chief Executive ...

L'Oréal was selling 29,556,650 shares at €101.50 each, meaning its stake in Sanofi will decrease from 9.4% to 7.2%. Both listed in Paris, L'Oréal opened 2.5% lower on 3 February following the ...

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to ...

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...